Stay updated on Belantamab vs Bortezomib in MM Clinical Trial

Sign up to get notified when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab vs Bortezomib in MM Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site revision changes from v3.7.2 to v3.8.0, while the study record remains unavailable behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T14:54:37.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T13:59:17.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T14:31:00.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T15:00:10.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now shows a 403 error replacing the study record. Key study documents and navigation to the trial details appear removed or hidden.
    Difference
    18%
    Check dated 2026-09-20T19:52:23.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The Related topics section no longer lists 'Multiple myeloma' or the 'MedlinePlus Genetics' resource. The 'related topics' heading has also been removed.
    Difference
    0.1%
    Check dated 2026-09-13T18:57:59.000Z thumbnail image

Stay in the know with updates to Belantamab vs Bortezomib in MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.